Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cardiac sodium channel protein (NaV1.5), encoded by the SCN5A gene, is a voltage-gated transmembrane protein essential for the rapid upstroke of the cardiac action potential and fast impulse conduction through heart tissue. It initiates cellular depolarization, which triggers and propagates electrical signals necessary for coordinated heart contractions. Mutations or dysfunctions in SCN5A/NaV1.5 can cause various inherited arrhythmia syndromes.
Block or modulate NaV1.5 activity; inhibit late/persistent INa component
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Sodium channel protein (cardiac) (NaV1.5).